Epidemiology studies investigating cell phone use patterns with human cancer risk have produced inconsistent results. Some studies enrolled people who already had tumors with suspected links to RF radiation, such as gliomas, acoustic neuromas and salivary gland tumors. Researchers compared the self-reported cell phone use habits of the cancer patients with those of other people who did not have the same diseases. Other studies enrolled people while they were still healthy, and then followed them over time to see if new cancer diagnoses tracked with how they used cell phones. All the epidemiology studies, however, have troubling limitations, including that enrolled subjects often do not report their cell phone use habits accurately on questionnaires.
If you paid an electrical engineer to shield something for you, depending on the application, they would either use MuMetal or this type of mesh shielding. It’s not some new technology, so there’s no question of whether it works, because it does. Regardless, it would still be nice for them to publish third-party independent testing to reassure people of this.
"On the same [IARC] scale that said phone use was possibly carcinogenic, smoking is at the highest level. They are class 1 carcinogens; that's beyond doubt, they definitely do cause cancer ... There's an absolute difference between substances, where the evidence says that there is no doubt about the fact that they cause cancer, compared to mobile phones, where they say it is still possible because the data over ten years use still isn't in."
Recall bias, which can occur when data about prior habits and exposures are collected from study participants using questionnaires administered after diagnosis of a disease in some of the participants. It is possible that study participants who have brain tumors may remember their cell phone use differently from individuals without brain tumors. Many epidemiologic studies of cell phone use and brain cancer risk lack verifiable data about the total amount of cell phone use over time. In addition, people who develop a brain tumor may have a tendency to recall cell phone use mostly on the same side of the head where their tumor was found, regardless of whether they actually used their phone on that side of the head a lot or only a little.
When called to help with the cell phone issue, Dr. Carlo was working with the FDA on silicone breast implant research. The choice of Dr. Carlo to head WTR seemed unusual to industry observers. An epidemiologist whose expertise was in public health and how epidemic diseases affect the population, he appeared to lack any experience in researching the effects of EMR on human biology. Based on this, a premature conclusion was drawn by many: Dr. Carlo was an “expert” handpicked by the cell phone industry, and therefore his conclusions would only back up the industry’s claim that cell phones are safe.
The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.
There are theoretical considerations as to why the possible risk should be investigated separately in children. Their nervous systems are still developing and, therefore, more vulnerable to factors that may cause cancer. Their heads are smaller than those of adults and consequently have a greater proportional exposure to the field of radiofrequency radiation that is emitted by cell phones. And, children have the potential of accumulating more years of cell phone exposure than adults do.
Searching PubMed for studies published in the past 10 years, we found 102 studies that ultimately resulted in 12 relevant systematic reviews. To limit bias in our assessment of the literature, we used a validated critical appraisal tool called AMSTAR to determine the quality of each review. Eight of the reviews were critically low quality, two were low quality, and two were moderate quality.
The 13-country INTERPHONE study, the largest case-control study done to date, looked at cell phone use among more than 5,000 people who developed brain tumors (gliomas or meningiomas) and a similar group of people without tumors. Overall, the study found no link between brain tumor risk and the frequency of calls, longer call time, or cell phone use for 10 or more years. There was a suggestion of a possible increased risk of glioma, and a smaller suggestion of an increased risk of meningioma, in the 10% of people who used their cell phones the most. But this finding was hard to interpret because some people in the study reported implausibly high cell phone use, as well as other issues. The researchers noted that the shortcomings of the study prevented them from drawing any firm conclusions, and that more research was needed.
What the study showed: Most published analyses from this study have shown no statistically significant increases in brain or central nervous system cancers related to higher amounts of cell phone use. One analysis showed a statistically significant, although modest, increase in the risk of glioma among the small proportion of study participants who spent the most total time on cell phone calls. However, the researchers considered this finding inconclusive because they felt that the amount of use reported by some respondents was unlikely and because the participants who reported lower levels of use appeared to have a slightly reduced risk of brain cancer compared with people who did not use cell phones regularly (4–6).